Home Hycells

Hycells

In operation
Series PreA
Cell and Gene Therapy (CGT) and Macromolecule Drug Developer
Basic
Enterprise Profile

Basic Information

Hycells is an innovative biotechnology company focusing on primary cells, related reagents, and technical services. The team has long been deeply involved in the fields of cell and gene therapy (CGT) and large-molecule drugs, committed to providing customers with one-stop solutions for primary cell products covering research and development, production, sales, and technical services.
--
Jiangsu,China
unclear
September 10, 2025
--
xiezhongming@hys-bio.com

Enterprise Profile

Industrial Sector
New Drug Development Immune Cell Therapy Gene Therapy
Technology
Gene Technology Cell Technology
Concept
Therapeutic Products
Application Scenarios
Innovative Drugs Cell and Gene Therapy